Good science doesn’t eliminate uncertainty: it explains it.
Academic rigor, journalistic flair
Articles on Ivermectin
Displaying all articles
Ivermectin is vital for controlling a number of neglected tropical diseases, but mixed messaging and reported side-effects from its misuse against COVID could turn patients off it.
Ivermectin has been a lifesaving drug for people with parasitic infections like river blindness and strongyloidiasis. But taking it for COVID-19 may result in the opposite effect.
The path to using old drugs for COVID is full of potholes. So why are we using the same old flawed methods when we actually know what works?
Medications to treat COVID-19 are in no way a substitute for the vaccine. But under the right circumstances, some show great promise for helping patients.
Ivermectin is the most recent example of a medication touted as a miracle drug for COVID-19 without solid medical evidence supporting its use.
Side-effects for this unproven and potentially dangerous treatment range from vomiting and diarrhoea to seizures and a coma.
Investigations have led to the withdrawal of a study backing ivermectin to treat COVID-19. But that’s not the last time we’ll hear about this controversial drug.
The antiparasitic drug was thought to be a potential treatment for COVID-19, but there isn’t sufficient evidence to recommend its use, despite widespread support online.
CC BY-NC-ND15.8 MB (download)
What’s all the excitement around ivermectin? Can it actually help treat COVID-19 patients?
The head lice drug ivermectin is being touted as a coronavirus killer. But studies suggest it would need to be taken in mega-doses far higher than those currently used, with unknown side-effects.
The head lice drug Ivermectin has stopped SARS-CoV-2, the virus that causes COVID-19, from replicating in lab tests. But we don’t know if it will work as a treatment for people with coronavirus.
A cure for many tropical diseases was discovered 30 years ago this month. The drug is donated by its manufacturer. Why are we still dealing with neglected tropical diseases?
Although a drug of known safety and efficacy is available, scabies still affects more than 100 million people across the world.
The 2015 Nobel Prize in medicine went to research on remedies derived from natural compounds. Academia is continuing the fight against ‘neglected’ diseases by similarly hunting for new drugs in nature.
Top contributors
-
Head of School and Dean of Pharmacy, University of Sydney
-
Senior Research Fellow in Global Health, University of Southampton
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Associate Professor of Chemistry, Northeastern University
-
Professor of Chemistry, Northeastern University
-
Group Leader, Murdoch Childrens Research Institute. Associate Professor, Department of Paediatrics, University of Melbourne. Paediatric Infectious Diseases Physician, Royal Children's Hospital, Murdoch Children's Research Institute
-
Professor: Evidence-Informed Decision-Making, University of Johannesburg
-
Ph.D. Candidate in Microbiology, Harvard University
-
Senior Lecturer in Pharmacology, Keele University
-
University of Johannesburg
-
Senior researcher at the Africa Centre for Evidence, University of Johannesburg
-
Associate Professor of Pharmacy, University of Connecticut
-
Senior Lecturer, University of Sydney
-
Research Professor in Medicinal Chemistry and Drug Discovery, Monash Institute of Pharmaceutical Sciences, Monash University
-
PhD Candidate, Quantitative Life Sciences, McGill University
